Activities

Activities per year 2006 2007 2008 2010 2018 2021 2022 2022

• 10 Participation in conference
• 7 Talk or presentation at a conference
• 3 Talk or presentation at a workshop/seminar

Activities per year

Search results

• A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).

  Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor) & Bart Neyns (Contributor)

  26 Mar 2022

  Activity: Talk or presentation › Talk or presentation at a conference

• A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).

  Wietse Geens (Speaker), Julia Katharina Schwarze (Contributor), Cleo Bertels (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), F Vaeyens (Contributor), Louise Cras (Contributor), Anne Vanbinst (Contributor), Hendrik Everaert (Contributor), Alex Michotte (Contributor), Toon Janssen (Contributor), Ben Caljon (Contributor), Thomas Cauwenbergh (Contributor), Michaël Bruneau (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)

  26 Mar 2022

  Activity: Talk or presentation › Talk or presentation at a conference

• Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.

  Wietse Geens (Speaker), Stephanie Du Four (Contributor), S VAN LAERE (Contributor), Julia Katharina Schwarze (Contributor), Gil Awada (Contributor), Michaël Bruneau (Contributor), Jens Tijtgat (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Johnny Duerinck (Contributor)

  26 Mar 2022

  Activity: Talk or presentation › Talk or presentation at a conference

• Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): a multi-cohort adaptive phase I clinical trial

  Julia Katharina Schwarze (Speaker), Wietse Geens (Contributor), Jens Tijtgat (Contributor), Gil Awada (Contributor), Anne-Marie Van Binst (Contributor), Hendrik Everaert (Contributor), Laura Seynaeve (Contributor), Alex Michotte (Contributor), Michaël Bruneau (Contributor), I VAN RIET (Contributor), Sandra Tuyaerts (Contributor), Johnny Duerinck (Contributor) & Bart Neyns (Contributor)

  16 Sep 2021 → 21 Sep 2021

  Activity: Talk or presentation › Talk or presentation at a conference

• Human relevant models for drug research and development

  Fien Meeus (Speaker), Robin Maximilian Awad (Contributor), Nick Devoogdt (Contributor), Sandra Tuyaerts (Contributor), Cleo Goyvaerts (Contributor), Yannick De Vlaeminck (Contributor), Bart Neyns (Contributor) & Karine Breckpot (Contributor)

  8 Oct 2021

  Activity: Talk or presentation › Talk or presentation at a workshop/seminar

• A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma

  Julia Katharina Schwarze (Presenter), Jens Tijtgat (Contributor), Gil Awada (Contributor), Louise Cras (Contributor), Inès Dufait (Contributor), Ramses Forsyth (Contributor), Sandra Tuyaerts (Contributor) & Bart Neyns (Contributor)

  17 Sep 2021

  Activity: Talk or presentation › Talk or presentation at a conference

• Melanomen

  Guy Verfaillie (Speaker), Valerie Vandersleyen (Speaker) & Bart Neyns (Speaker)

  19 Feb 2019

  Activity: Talk or presentation › Talk or presentation at a workshop/seminar

• Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

  Gil Awada (Speaker), Ibrahim Özdemir (Contributor), Julia Katharina Schwarze (Contributor), Emma Daeninck (Contributor), Odrade Gondry (Contributor), Yanina Jansen (Contributor), Teofila Seremet (Contributor), Marleen Keyaerts (Contributor), Hendrik Everaert (Contributor) & Bart Neyns (Contributor)

  14 Dec 2018

  Activity: Talk or presentation › Talk or presentation at a conference

• Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab

  Odrade Gondry (Speaker), Ibrahim Özdemir (Contributor), Yanina Jansen (Contributor), Gil Awada (Contributor), Julia Katharina Schwarze (Contributor), Teofila Seremet (Contributor), Hendrik Everaert (Contributor), Bart Neyns (Contributor) & Marleen Keyaerts (Contributor)

  19 Oct 2018

  Activity: Talk or presentation › Talk or presentation at a workshop/seminar

• Incidence of thyroid immune-related adverse events in melanoma patients treated with pembrolizumab in an expanded access program

  Jeroen De Filette (Speaker), Yanina Jansen (Contributor), Max Schreuer (Contributor), Bert Bravenboer (Contributor), Bart Neyns (Contributor) & Brigitte Velkeniers-Hoebanckx (Contributor)

  30 Jan 2016

  Activity: Talk or presentation › Talk or presentation at a conference

• 35th european Society for Medical Oncology congress

  Bart Neyns (Participant)

  8 Dec 2010 → 12 Dec 2010

  Activity: Participating in or organising an event › Participation in conference

• Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research conference

  Bart Neyns (Participant)

  9 Dec 2010 → 12 Dec 2010

  Activity: Participating in or organising an event › Participation in conference

• 9th meeting of european Assocoation of Neuro-oncology

  Bart Neyns (Participant)

  16 Sep 2010 → 19 Sep 2010

  Activity: Participating in or organising an event › Participation in conference

• 45th Annual Meeting of the American Society of Clinical Oncology

  Bart Neyns (Participant)

  29 May 2009 → 2 Jun 2009

  Activity: Participating in or organising an event › Participation in conference

• 33rd European Society for Medical Oncology congress

  Bart Neyns (Participant)

  12 Sep 2008 → 16 Sep 2008

  Activity: Participating in or organising an event › Participation in conference

• 8th congress of the European Association for Neuro-Oncology

  Bart Neyns (Participant)

  12 Sep 2008 → 14 Sep 2008

  Activity: Participating in or organising an event › Participation in conference

• 11th Congress of the European Federation of Neurological Societies

  Bart Neyns (Participant)

  25 Aug 2007 → 28 Aug 2007

  Activity: Participating in or organising an event › Participation in conference

• 12th annual meeting of the society for Neuro-oncology

  Bart Neyns (Participant)

  15 Nov 2007 → 18 Nov 2007

  Activity: Participating in or organising an event › Participation in conference

• 9th world congress on Gastrotestinal Cancer

  Bart Neyns (Participant)

  28 Jul 2007 → 1 Aug 2007

  Activity: Participating in or organising an event › Participation in conference

• 31st congress of the European Society for Medical Oncology

  Bart Neyns (Participant)

  29 Sep 2006 → 3 Oct 2006

  Activity: Participating in or organising an event › Participation in conference